Saltar al contenido

LifeStance Health Group, Inc. (LFST) stock: revenue, earnings & dividend

LifeStance Health Group, Inc. (LFST, Nasdaq): revenue, earnings, dividend and balance sheet from official SEC filings.

Stock screener LFST · Nasdaq Gesundheitswesen US-AZ

Key figures

Fiscal year
2025
Revenue
1.42 bn $
Revenue growth
13.9 %
Revenue growth 5y (p.a.)
–
Net income
9.66 m $
Net margin
0.7 %
Operating margin
1.7 %
Earnings per share (diluted)
–
Dividend per share
–
Payout ratio
–
Consecutive dividend years
–
Consecutive dividend raises
–
Dividend growth 5y (p.a.)
–
Total assets
2.2 bn $
Equity
1.52 bn $
Equity ratio
69 %
Return on equity
0.6 %
Cash
249 m $
Operating cash flow
146 m $
Free cash flow
110 m $
Shares outstanding
380,190,724

History

Revenue by fiscal year

2019 213 m $
2021 668 m $
2022 860 m $
2023 1.06 bn $
2024 1.25 bn $
2025 1.42 bn $

Net income by fiscal year

2019 5.67 m $
2021 -307.2 m $
2022 -215.56 m $
2023 -186.26 m $
2024 -57.44 m $
2025 9.66 m $
YearRevenueNet incomeEPSDividend per shareOperating cash flow
20251.42 bn $9.66 m $––146 m $
20241.25 bn $-57.44 m $––107 m $
20231.06 bn $-186.26 m $––-16.88 m $
2022860 m $-215.56 m $––52.8 m $
2021668 m $-307.2 m $––9.42 m $
2019213 m $5.67 m $––17 m $

Data from XBRL filings at the SEC, processed automatically, no guarantee. Not investment advice. All filings at the SEC (EDGAR)